5-[2-methylsulfonyl-6-[4-(pyrrolidin-3-ylmethyl)cyclohexyl]-3-(trifluoromethyl)phenyl]-2H-tetrazole;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexan-1-amine;[4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexyl]methanamine;3-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]propan-1-amine

C125H168F18N30O12S6 — CID 158013520

IUPAC5-[2-methylsulfonyl-6-[4-(pyrrolidin-3-ylmethyl)cyclohexyl]-3-(trifluoromethyl)phenyl]-2H-tetrazole;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexan-1-amine;[4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexyl]methanamine;3-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]propan-1-amine
SMILESCS(=O)(=O)c1c(C(F)(F)F)ccc(C2CCC(CC3CCC(CN)CC3)CC2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(C2CCC(CC3CCC(N)CC3)CC2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(C2CCC(CC3CCCNC3)CC2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(C2CCC(CC3CCNC3)CC2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(C2CCC(CC3CCNCC3)CC2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(C2CCC(CCCN)CC2)c1-c1nn[nH]n1
InChIInChI=1S/C23H32F3N5O2S.C22H30F3N5O2S.2C21H28F3N5O2S.C20H26F3N5O2S.C18H24F3N5O2S/c1-34(32,33)21-19(23(24,25)26)11-10-18(20(21)22-28-30-31-29-22)17-8-6-15(7-9-17)12-14-2-4-16(13-27)5-3-14;1-33(31,32)20-18(22(23,24)25)11-10-17(19(20)21-27-29-30-28-21)15-6-2-13(3-7-15)12-14-4-8-16(26)9-5-14;1-32(30,31)19-17(21(22,23)24)7-6-16(18(19)20-26-28-29-27-20)15-4-2-13(3-5-15)12-14-8-10-25-11-9-14;1-32(30,31)19-17(21(22,23)24)9-8-16(18(19)20-26-28-29-27-20)15-6-4-13(5-7-15)11-14-3-2-10-25-12-14;1-31(29,30)18-16(20(21,22)23)7-6-15(17(18)19-25-27-28-26-19)14-4-2-12(3-5-14)10-13-8-9-24-11-13;1-29(27,28)16-14(18(19,20)21)9-8-13(15(16)17-23-25-26-24-17)12-6-4-11(5-7-12)3-2-10-22/h10-11,14-17H,2-9,12-13,27H2,1H3,(H,28,29,30,31);10-11,13-16H,2-9,12,26H2,1H3,(H,27,28,29,30);6-7,13-15,25H,2-5,8-12H2,1H3,(H,26,27,28,29);8-9,13-15,25H,2-7,10-12H2,1H3,(H,26,27,28,29);6-7,12-14,24H,2-5,8-11H2,1H3,(H,25,26,27,28);8-9,11-12H,2-7,10,22H2,1H3,(H,23,24,25,26)
InChIKeyFFELCINUYQDGMO-UHFFFAOYSA-N
MW2817.28 g/mol
LogP23.96
Rot. Bonds32

About 5-[2-methylsulfonyl-6-[4-(pyrrolidin-3-ylmethyl)cyclohexyl]-3-(trifluoromethyl)phenyl]-2H-tetrazole;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexan-1-amine;[4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexyl]methanamine;3-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]propan-1-amine

5-[2-methylsulfonyl-6-[4-(pyrrolidin-3-ylmethyl)cyclohexyl]-3-(trifluoromethyl)phenyl]-2H-tetrazole;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexan-1-amine;[4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexyl]methanamine;3-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]propan-1-amine (PubChem CID 158013520) has the molecular formula C125H168F18N30O12S6 and a molecular weight of 2817.28 g/mol. Its IUPAC name is 5-[2-methylsulfonyl-6-[4-(pyrrolidin-3-ylmethyl)cyclohexyl]-3-(trifluoromethyl)phenyl]-2H-tetrazole;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexan-1-amine;[4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexyl]methanamine;3-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]propan-1-amine.

Molecular Properties

Compound Name5-[2-methylsulfonyl-6-[4-(pyrrolidin-3-ylmethyl)cyclohexyl]-3-(trifluoromethyl)phenyl]-2H-tetrazole;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexan-1-amine;[4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexyl]methanamine;3-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]propan-1-amine
PubChem CID158013520
Molecular FormulaC125H168F18N30O12S6
Molecular Weight2817.28 g/mol
Exact Mass2815.15
IUPAC Name5-[2-methylsulfonyl-6-[4-(pyrrolidin-3-ylmethyl)cyclohexyl]-3-(trifluoromethyl)phenyl]-2H-tetrazole;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexan-1-amine;[4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexyl]methanamine;3-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]propan-1-amine
SMILESCS(=O)(=O)c1c(C(F)(F)F)ccc(C2CCC(CC3CCC(CN)CC3)CC2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(C2CCC(CC3CCC(N)CC3)CC2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(C2CCC(CC3CCCNC3)CC2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(C2CCC(CC3CCNC3)CC2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(C2CCC(CC3CCNCC3)CC2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(C2CCC(CCCN)CC2)c1-c1nn[nH]n1
InChIInChI=1S/C23H32F3N5O2S.C22H30F3N5O2S.2C21H28F3N5O2S.C20H26F3N5O2S.C18H24F3N5O2S/c1-34(32,33)21-19(23(24,25)26)11-10-18(20(21)22-28-30-31-29-22)17-8-6-15(7-9-17)12-14-2-4-16(13-27)5-3-14;1-33(31,32)20-18(22(23,24)25)11-10-17(19(20)21-27-29-30-28-21)15-6-2-13(3-7-15)12-14-4-8-16(26)9-5-14;1-32(30,31)19-17(21(22,23)24)7-6-16(18(19)20-26-28-29-27-20)15-4-2-13(3-5-15)12-14-8-10-25-11-9-14;1-32(30,31)19-17(21(22,23)24)9-8-16(18(19)20-26-28-29-27-20)15-6-4-13(5-7-15)11-14-3-2-10-25-12-14;1-31(29,30)18-16(20(21,22)23)7-6-15(17(18)19-25-27-28-26-19)14-4-2-12(3-5-14)10-13-8-9-24-11-13;1-29(27,28)16-14(18(19,20)21)9-8-13(15(16)17-23-25-26-24-17)12-6-4-11(5-7-12)3-2-10-22/h10-11,14-17H,2-9,12-13,27H2,1H3,(H,28,29,30,31);10-11,13-16H,2-9,12,26H2,1H3,(H,27,28,29,30);6-7,13-15,25H,2-5,8-12H2,1H3,(H,26,27,28,29);8-9,13-15,25H,2-7,10-12H2,1H3,(H,26,27,28,29);6-7,12-14,24H,2-5,8-11H2,1H3,(H,25,26,27,28);8-9,11-12H,2-7,10,22H2,1H3,(H,23,24,25,26)
InChIKeyFFELCINUYQDGMO-UHFFFAOYSA-N
XLogP23.96
TPSA645.75 Ų
H-Bond Donors12
H-Bond Acceptors36
Rotatable Bonds32
Heavy Atoms191
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002817.28
LogP ≤ 523.96
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1036

Analyze 5-[2-methylsulfonyl-6-[4-(pyrrolidin-3-ylmethyl)cyclohexyl]-3-(trifluoromethyl)phenyl]-2H-tetrazole;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexan-1-amine;[4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexyl]methanamine;3-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]propan-1-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-[2-methylsulfonyl-6-[4-(pyrrolidin-3-ylmethyl)cyclohexyl]-3-(trifluoromethyl)phenyl]-2H-tetrazole;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexan-1-amine;[4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexyl]methanamine;3-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]propan-1-amine?
The IUPAC name of 5-[2-methylsulfonyl-6-[4-(pyrrolidin-3-ylmethyl)cyclohexyl]-3-(trifluoromethyl)phenyl]-2H-tetrazole;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexan-1-amine;[4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexyl]methanamine;3-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]propan-1-amine (CID 158013520) is 5-[2-methylsulfonyl-6-[4-(pyrrolidin-3-ylmethyl)cyclohexyl]-3-(trifluoromethyl)phenyl]-2H-tetrazole;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexan-1-amine;[4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexyl]methanamine;3-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]propan-1-amine.
What is the SMILES notation for 5-[2-methylsulfonyl-6-[4-(pyrrolidin-3-ylmethyl)cyclohexyl]-3-(trifluoromethyl)phenyl]-2H-tetrazole;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexan-1-amine;[4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexyl]methanamine;3-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]propan-1-amine?
The canonical SMILES for 5-[2-methylsulfonyl-6-[4-(pyrrolidin-3-ylmethyl)cyclohexyl]-3-(trifluoromethyl)phenyl]-2H-tetrazole;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexan-1-amine;[4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexyl]methanamine;3-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]propan-1-amine is CS(=O)(=O)c1c(C(F)(F)F)ccc(C2CCC(CC3CCC(CN)CC3)CC2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(C2CCC(CC3CCC(N)CC3)CC2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(C2CCC(CC3CCCNC3)CC2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(C2CCC(CC3CCNC3)CC2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(C2CCC(CC3CCNCC3)CC2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(C2CCC(CCCN)CC2)c1-c1nn[nH]n1.
What is the InChIKey of 5-[2-methylsulfonyl-6-[4-(pyrrolidin-3-ylmethyl)cyclohexyl]-3-(trifluoromethyl)phenyl]-2H-tetrazole;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexan-1-amine;[4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexyl]methanamine;3-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]propan-1-amine?
The InChIKey is FFELCINUYQDGMO-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H32F3N5O2S.C22H30F3N5O2S.2C21H28F3N5O2S.C20H26F3N5O2S.C18H24F3N5O2S/c1-34(32,33)21-19(23(24,25)26)11-10-18(20(21)22-28-30-31-29-22)17-8-6-15(7-9-17)12-14-2-4-16(13-27)5-3-14;1-33(31,32)20-18(22(23,24)25)11-10-17(19(20)21-27-29-30-28-21)15-6-2-13(3-7-15)12-14-4-8-16(26)9-5-14;1-32(30,31)19-17(21(22,23)24)7-6-16(18(19)20-26-28-29-27-20)15-4-2-13(3-5-15)12-14-8-10-25-11-9-14;1-32(30,31)19-17(21(22,23)24)9-8-16(18(19)20-26-28-29-27-20)15-6-4-13(5-7-15)11-14-3-2-10-25-12-14;1-31(29,30)18-16(20(21,22)23)7-6-15(17(18)19-25-27-28-26-19)14-4-2-12(3-5-14)10-13-8-9-24-11-13;1-29(27,28)16-14(18(19,20)21)9-8-13(15(16)17-23-25-26-24-17)12-6-4-11(5-7-12)3-2-10-22/h10-11,14-17H,2-9,12-13,27H2,1H3,(H,28,29,30,31);10-11,13-16H,2-9,12,26H2,1H3,(H,27,28,29,30);6-7,13-15,25H,2-5,8-12H2,1H3,(H,26,27,28,29);8-9,13-15,25H,2-7,10-12H2,1H3,(H,26,27,28,29);6-7,12-14,24H,2-5,8-11H2,1H3,(H,25,26,27,28);8-9,11-12H,2-7,10,22H2,1H3,(H,23,24,25,26).
What are the key properties of 5-[2-methylsulfonyl-6-[4-(pyrrolidin-3-ylmethyl)cyclohexyl]-3-(trifluoromethyl)phenyl]-2H-tetrazole;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexan-1-amine;[4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexyl]methanamine;3-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]propan-1-amine?
5-[2-methylsulfonyl-6-[4-(pyrrolidin-3-ylmethyl)cyclohexyl]-3-(trifluoromethyl)phenyl]-2H-tetrazole;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexan-1-amine;[4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexyl]methanamine;3-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]propan-1-amine has a molecular weight of 2817.28 g/mol, XLogP of 23.96, 32 rotatable bonds, 12 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[2-methylsulfonyl-6-[4-(pyrrolidin-3-ylmethyl)cyclohexyl]-3-(trifluoromethyl)phenyl]-2H-tetrazole;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexan-1-amine;[4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]cyclohexyl]methanamine;3-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;4-[[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]methyl]piperidine;3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]cyclohexyl]propan-1-amine is sourced from PubChem (CID 158013520), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).